NNVC Nanoviricides Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: NNVC

Price (delayed)

$1.31

Market cap

$28.36M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.43

Enterprise value

$25.14M

?
Relative Growth: Rel. Growth: 17
Relative Strength: Rel. Strength: 57
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 8

NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack enveloped ...

Highlights
The EPS has grown by 39% YoY and by 10% from the previous quarter
NNVC's net income is up by 17% YoY and by 2.7% QoQ
NNVC's quick ratio is up by 42% year-on-year but it is down by 30% since the previous quarter
The equity has declined by 17% since the previous quarter but it has grown by 3.6% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.nanoviricides.com
Peers: BCRX NVAX GILD BMY

Key stats

What are the main financial stats of NNVC

NNVC stock price

How has the Nanoviricides stock price performed over time
Intraday
-0.76%
1 week
-3.68%
1 month
-20.12%
1 year
-4.38%
YTD
15.93%
QTD
43.62%

Financial performance

How have Nanoviricides's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.18M
Net income
-$8.09M
Gross margin
N/A
Net margin
N/A
NNVC's net income is up by 17% YoY and by 2.7% QoQ
Nanoviricides's operating income has increased by 17% YoY and by 2.6% QoQ

Price vs fundamentals

How does NNVC's price correlate with its fundamentals

Growth

What is Nanoviricides's growth rate over time

Valuation

What is Nanoviricides stock price valuation
P/E
N/A
P/B
3.09
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 39% YoY and by 10% from the previous quarter
The stock's price to book (P/B) is 93% more than its 5-year quarterly average of 1.6 and 19% more than its last 4 quarters average of 2.6
The equity has declined by 17% since the previous quarter but it has grown by 3.6% year-on-year

Efficiency

How efficient is Nanoviricides business performance
Nanoviricides's return on invested capital has increased by 11% YoY
Nanoviricides's return on equity has increased by 3.6% QoQ and by 2.8% YoY
NNVC's return on assets is up by 3.2% since the previous quarter and by 3.2% year-on-year

Dividends

What is NNVC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NNVC.

Financial health

How did Nanoviricides financials performed over time
NNVC's quick ratio is up by 42% year-on-year but it is down by 30% since the previous quarter
The current ratio has increased by 40% YoY but it has decreased by 28% QoQ
NNVC's debt is 100% lower than its equity
The equity has declined by 17% since the previous quarter but it has grown by 3.6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.